Andrews Liver Salts Effervescent Powder
- Name:
Andrews Liver Salts Effervescent Powder
- Company:
GlaxoSmithKline Consumer Healthcare (Ireland) Ltd
- Active Ingredients:
Citric Acid (Anhydrous), Magnesium sulfate (dihydrate), Sodium Hydrogen Carbonate
- Legal Category:
Supply through general sale
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 03/05/16


Print ViewKeyword Search SPC
1. NAME OF THE MEDICINAL PRODUCT
1. NAME OF THE MEDICINAL PRODUCT
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
3. PHARMACEUTICAL FORM
3. PHARMACEUTICAL FORM
4. CLINICAL PARTICULARS
4. CLINICAL PARTICULARS
5. PHARMACOLOGICAL PROPERTIES
5. PHARMACOLOGICAL PROPERTIES
6. PHARMACEUTICAL PARTICULARS
6. PHARMACEUTICAL PARTICULARS
7. MARKETING AUTHORISATION HOLDER
7. MARKETING AUTHORISATION HOLDER
8. MARKETING AUTHORISATION NUMBER(S)
8. MARKETING AUTHORISATION NUMBER(S)
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
10. DATE OF REVISION OF THE TEXT
10. DATE OF REVISION OF THE TEXT
GlaxoSmithKline Consumer Healthcare (Ireland) Ltd
 Ltd.jpg)
Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 3 May 2016 PIL
Reasons for updating
- Change to MA holder contact details
Updated on 3 May 2016 PIL
Reasons for updating
- New PIL for new product
Updated on 10 July 2015 SPC
Reasons for updating
- New SPC for new product
Legal category: Supply through general sale
Updated on 10 July 2015 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
Legal category: Supply through general sale
Free text change information supplied by the pharmaceutical company
Section 7
Marketing Authorisation Holder address updated to:
12 Riverwalk,
Citywest Business Campus,
Dublin 24,
Ireland
Updated on 22 May 2015 SPC
Reasons for updating
- Change to Section 4.8 – Undesirable effects - how to report a side effect
Legal category: Supply through general sale
Free text change information supplied by the pharmaceutical company
Updated on 21 May 2015 PIL
Reasons for updating
- Change to side-effects
Updated on 3 December 2012 PIL
Reasons for updating
- Change due to harmonisation of PIL
Updated on 13 August 2010 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change of contraindications
- Change to information about pregnancy or lactation
Updated on 24 August 2009 SPC
Reasons for updating
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
Legal category: Supply through general sale
Free text change information supplied by the pharmaceutical company
Section 4.4: Addition of warning re sugar intolerances.
Section 4.6: Addition of warnings re pergnancy.
Updated on 20 February 2009 SPC
Reasons for updating
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
Legal category: Supply through general sale
Free text change information supplied by the pharmaceutical company
This product should not be given to patients with a hypersensitivity to any component of Andrews Liver Salts or any previous hypersensitivity to Andrews Liver Salts.
Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
Updated on 28 August 2007 PIL
Reasons for updating
- Improved electronic presentation
Updated on 30 May 2007 PIL
Reasons for updating
- Improved electronic presentation
Updated on 22 May 2007 SPC
Reasons for updating
- Change to section 6.5 - Nature and contents of container
Legal category: Supply through general sale
Free text change information supplied by the pharmaceutical company
6.5 Nature and Contents of Container
Removal of reference to 'integral 5 ml spoon'
Updated on 20 April 2007 SPC
Reasons for updating
- Change to section 1 - Name of medicinal product
- Change to section 6.4 - Special precautions for storage
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category: Supply through general sale
Free text change information supplied by the pharmaceutical company
1. Name of the medicinal product
Change name to: Andrews Liver Salts Effervescent Powder
6.4 Special Precautions for Storage
Amend wording as follows: Keep the container tightly closed.
6.5 Nature and Contents of Container
Include statement: Not all pack sizes may be marketed.
10. Date of revision of text
April 2007
Updated on 18 November 2004 PIL
Reasons for updating
- New PIL for medicines.ie
Updated on 20 August 2003 SPC
Reasons for updating
- Improved electronic presentation
Legal category: Supply through general sale
Updated on 19 August 2003 SPC
Reasons for updating
- Improved electronic presentation
Legal category: Supply through general sale
Updated on 12 August 2003 SPC
Reasons for updating
- Improved electronic presentation
Legal category: Supply through general sale
Updated on 25 June 2003 SPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Supply through general sale